Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
Patents for C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups (27,160)
10/2005
10/27/2005WO2005061433A3 Aminoalcohol derivatives
10/27/2005WO2005058005A3 Process for synthesizing disulfides
10/27/2005US20050240060 Low loss high refractive index vinyl sulfide compounds and method of making same
10/27/2005US20050240049 Process for the preparation of substituted tetralin and substituted indane derivatives
10/27/2005US20050240048 Reacting methylmercaptan and acrolein in the presence of a catalyst of an acid and N-alkyl-morpholine
10/27/2005US20050239881 viricides; polymerase inhibitors; therapy for genetic engineered virus
10/27/2005US20050239849 Substituted phenoxyacetic acids
10/27/2005US20050239802 E.g., 6-{2-[5-Chloro-2-(2,4-difluorobenzyloxy)- phenyl]cyclopent-1-enyl}-pyridine-2-carboxylic acid, used to treat prostaglandin mediated diseases that include inflammatory, neuropathic or visceral pain
10/27/2005US20050239754 S-[2-[(1-Iminoethyl)amino]ethyl]-2-methyl-L-cysteine salicylate monohydrate crystalline salt
10/27/2005US20050238978 Azine-based charge transport materials
10/27/2005US20050238972 high charge-transporting ability; prepared without using a phosphorus reaction reagent; friendly to global environment; unsaturated naphthylamines
10/27/2005CA2563291A1 4-cyano-phenoxy-alkyl carboxyl derivatives as androgen modulators
10/27/2005CA2562554A1 Thio-substituted arylmethanesulfinyl derivatives
10/27/2005CA2562401A1 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
10/27/2005CA2561555A1 Bicyclic aromatic sulfinyl derivatives
10/27/2005CA2561554A1 Tricyclic aromatic and bis-phenyl sulfinyl derivatives
10/26/2005EP1589016A1 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
10/26/2005EP1589001A1 Tricyclic aromatic and bis-phenyl sulfinyl derivatives
10/26/2005EP1589000A2 (R)-Chiral halogenated 1-substitutedamino-(N+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity
10/26/2005EP1587781A1 3-aryloxy/thio-2,3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake
10/26/2005EP1587508A1 Therapeutic use of acylglycerols and the nitrogen- and sulphur-containing analogues thereof
10/26/2005EP1183229B1 Glucagon antagonists/inverse agonists
10/26/2005EP1129071B1 Phenyl-substituted cyclic enaminones
10/26/2005CN1688647A Graftable 4-amino-3-sulfinyl-substitued diphenylamine stabilizers for vulcanizates
10/26/2005CN1688540A Novel vinyl carboxylic acid derivatives and their therapeutical use
10/26/2005CN1688532A Composition based on substituted 1, 3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof
10/26/2005CN1688298A Composition, synthesis and therapeutic applications of polyamines
10/26/2005CN1687027A Anhydrous tiopronin natrium for curing acute or chronic liver disease and preparation method
10/26/2005CN1224613C Process for recovering sodium mercaptoacetate from production of thia amino-ester waste liquid
10/26/2005CN1224612C Acetylenic sulfonamide thiol TACE inhibitors
10/26/2005CN1224598C Naphthalene derivatives
10/25/2005US6958419 Alkynyl S,N-acetal derivative and method of producing the same
10/25/2005US6958352 Compounds for inhibiting insulin secretion and methods related thereto
10/25/2005CA2147056C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
10/20/2005WO2005097734A1 Method of purifying amino acid
10/20/2005US20050234131 Novel ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof
10/20/2005US20050234125 Alpha-sulfonylamino-acetonitriles
10/20/2005US20050234109 to treat Alzheimer's disease,Down syndrome and the other diseases associated with amyloid deposition; thiomethane, sulfinylmethane or sulfonylmethane compounds; 5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]-2-(4'-hydroxypiperidin-1'-yl)pyridine
10/20/2005US20050234106 1-aryl-1-heteroarylaminoalkylene-substituted, e.g., 1-[fluorophenylcyclohexylmethyl]isoquinolin-1-ylamine; antiarrhythmia agents; cardiovascular disorders
10/20/2005US20050234061 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/20/2005US20050234040 Tricyclic aromatic and bis-phenyl sulfinyl derivatives
10/20/2005US20050232928 Drug conjugates
10/19/2005EP1586561A1 Bicyclic aromatic sulfinyl derivatives
10/19/2005EP1586560A1 Thio-substituted arylmethanesulfinyl derivatives
10/19/2005EP1586559A1 Biaryl-methanethio-, -sulphinyl- and sulphonyl derivatives
10/19/2005EP1585745A1 Fc receptor modulating compounds and compositions
10/19/2005EP1585521A2 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone
10/19/2005EP1463714A4 Vanilloid receptor ligands and their use in treatments
10/19/2005EP1322597A4 Process and intermediates
10/19/2005EP1075260B1 Novel fatty acid analogues for the treatment of secondary restenosis
10/19/2005CN1684944A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/19/2005CN1683333A Method for using antural clarifying bacteriostat in organ extraction
10/19/2005CN1682702A Method for preparing medicine composition capable of inhibiting post infective virus proteinase
10/19/2005CN1223343C Novel fatty analogues for the treatment of obesity, hypertension and fatty liver
10/18/2005US6956059 use in relief of rheumatoid arthritis, rheumatoid spondylitis, osteroarthritis, gouty arthritis and other arthritic conditions, inflamed joints, eczema and other inflammatory skin conditions, inflammatory eye conditions, aids, hiv
10/18/2005US6956013 Requiring multistep reaction sequence preventing premature odor release; storage stable
10/18/2005US6955888 Methods of screening agents, conjugates or conjugate moieties for transport by a PEPT2 transporter
10/18/2005CA2294171C N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
10/13/2005WO2005095941A1 Mass analysis method using fine metal particles
10/13/2005WO2005095343A1 Dpp-iv inhibitors
10/13/2005WO2005095334A1 Sulfonamide compounds for the treatment of neurodegenerative disorders
10/13/2005WO2005095327A1 Aniline derivatives
10/13/2005WO2005095326A2 2-amino- and 2-thio-substituted 1,3-diaminopropanes
10/13/2005US20050228192 Forming a salt of probucol or a derivative by reaction with an alkali metal or ammonium compound in a ketone solvent and reacting the product with alkanoic anhydride to form a carboxyalkyl mono- or diester
10/13/2005US20050228040 Bicyclic aromatic sulfinyl derivatives
10/13/2005US20050228015 Substituted heteroaryl- and phenylsulfamoyl compounds
10/13/2005US20050227994 Decomposition inhibitor for extracellular matrix of cartilage
10/13/2005US20050227990 Aminoalkoxy-functional chalcones
10/13/2005US20050227986 Vanilloid receptor ligands and their use in treatments
10/13/2005US20050227979 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety
10/13/2005CA2562114A1 Sulfonamide compounds for the treatment of neurodegenerative disorders
10/13/2005CA2560773A1 2-amino- and 2-thio-substituted 1,3-diaminopropanes
10/13/2005CA2558446A1 Dpp-iv inhibitors
10/12/2005EP1584986A2 Poly(azine)-based charge transport materials
10/12/2005EP1584615A1 Use of dimercaptoamides for permanently deforming of keratinic fibres
10/12/2005EP1583739A1 Method for preparing methyl 2-diphenylmethylsulfinylacetate
10/12/2005EP1583738A1 Indenoncarboxylic acids derivatives and their use for the treatment of and preventing diabetes and dyslipidaemia
10/12/2005EP1583726A2 Activity-based probes, and methods of their preparation and use
10/12/2005EP1049793B1 Transfecting compositions sensitive to reducing conditions, pharmaceutical compositions containing them, and their applications
10/12/2005EP0977563B1 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
10/12/2005CN1681776A Amino alcohol derivative, addition salt thereof, and immunosuppressant
10/12/2005CN1681763A Chemical compounds
10/12/2005CN1681490A Melanin extinguisher
10/12/2005CN1680402A Water soluble prodrugs of hindered alcohols
10/12/2005CN1680364A Method for producing lipoic acid and dihydrolipoic acid
10/12/2005CN1680338A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2005CN1680311A Process for producing methionine
10/12/2005CN1680308A New 3-aryl-2-hydroxypropionic acid derivative I
10/12/2005CN1680272A C2-phenyl-substituted cyclic keto-enols used as pesticides and herbicides
10/12/2005CN1679488A Use of dimercaptoamides for permanently deforming of keratinic fibres
10/11/2005US6953812 Carboxy and amide containing compound suitable for treatment and/or prevention of diseases wherein a glucagon antagonistic action is beneficial, such as hyperglycemia, diabetes, disorders of the lipid metabolism, such as dyslipidemia
10/11/2005US6953797 Nitric oxide synthase inhibitor; antiinflammatory agents
10/06/2005WO2005092997A1 Surface treating agent, fluorine-containing monomer and fluorine-containing polymer
10/06/2005WO2005092937A1 Fluorine-containing monomer, fluorine-containing polymer and surface treating agent
10/06/2005WO2005092848A1 Novel perfluoroalkyl hydrophobic and oil-repellent surfactants derived from substituted amides, preparation and use thereof
10/06/2005WO2005092847A1 Dendron and dendrimer, method of producing the same, and method of producing a thioacetal compound
10/06/2005WO2005092845A1 Substituted heteroaryl- and phenylsulfamoyl compounds
10/06/2005WO2005092840A1 Formamide derivatives useful as adrenoceptor
10/06/2005WO2005092836A1 Opioid receptor antagonists
10/06/2005WO2005092835A1 Pharmaceutical compounds
1 ... 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 ... 272